english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

The annual Prescrire Awards are given out in Paris: 5 winning drugs, but no "Pilule d'Or"

Palmarès des médicaments de Prescrire The independent French medical journal Prescrire announced its Drug Awards for 2018, at its yearly awards ceremony in Paris on 31 January. There was no "Pilule d'Or" (Golden Pill) award, but two drugs made the "Honours List" and three others were recognised as "Noteworthy".
1 February 2019

The Prescrire Drug Packaging Awards for 2018: no winners and a lot of losers

Palmarès du conditionnement de Prescrire The independent French medical journal Prescrire held its annual awards ceremony in Paris on 31 January. There were no Packaging Awards this year, whereas 25 "Yellow Cards" or "Red Cards" were handed out for substandard or dangerous packaging.
1 February 2017

Prescrire's Information Awards for 2018: just 7 drug companies (out of 86 contacted) are honoured for the quality of information provided

Palmarès de l'information Prescrire's annual Information Awards recognise drug companies which respond to Prescrire's requests with complete and relevant information. The picture in 2018 was no better than in prior years: only a few drug companies embraced transparency, in the best interest of patients.
1 February 2019

Updated list of "Drugs to avoid, in the name of better patient care" is published by independent French journal Prescrire

Bilan des médicaments à écarterIn conjunction with the annual Prescrire Drug, Packaging and Information Awards, the independent French medical journal Prescrire has published its annual review identifying drugs that are clearly more harmful than beneficial. The full report will be published in English in the April issue of Prescrire International.
1 February 2019

Simple febrile seizures in a child. First-choice treatments

FEATURED REVIEW Febrile seizures occur in around 3% of children. What are the essential points for healthcare professionals to keep in mind? And what are the warning signs to look out for?
Full review (4 pages) available for download by subscribers.
1 February 2019

In the February issue of Prescrire International: Midostaurin (Rydapt°) for some types of acute myeloid leukaemia

FREE DOWNLOAD In this month's sample review, Prescrire's editors give this multi-tyrosine kinase inhibitor a rating of "Offers an advantage", but warn that the drug's adverse effects are underestimated.
Full text available for free download.
1 February 2019

MRI during pregnancy: the pros and cons should be carefully assessed

Before deciding to give a pregnant woman an MRI scan, with or without contrast agents, it is important to consider how the MRI results would change the clinical course.
1 February 2019

Proton pump inhibitors: increased mortality

FEATURED REVIEW Proton pump inhibitors (PPIs) such as omeprazole are used in oesophagitis, gastroesophageal reflux disease and peptic ulcer disease. PPIs have few severe adverse effects in the short term. But this is not the case in the long term.
Full review (3 pages) available for download by subscribers.
1 January 2019

In the January issue of Prescrire International: Pembrolizumab (Keytruda°) in urothelial carcinoma

FREE DOWNLOAD In this month's sample review: Prescrire's editors rate pembrolizumab (Keytruda°) "Possibly helpful" in certain patients with locally advanced or metastatic urothelial carcinoma.
Full text available for free download.
1 January 2019

Nonsteroidal anti-inflammatory drugs in pharyngitis: risk of peritonsillar abscess

To relieve fever or sore throat, it is better not to use nonsteroidal anti-inflammatory drugs (NSAIDs), but to use paracetamol instead.
1 January 2019

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90